The Nutrition cluster comprises DSM Food Specialties and DSM Nutritional Products. The nutrition and food ingredients businesses serve the food, feed, cosmetic and pharmaceutical industries. Activities are based on an in-depth knowledge of customer/market needs. With customized formulation activities in more than 44 locations and a marketing/sales presence reaching over 60 countries, customer intimacy is a key success factor. Technical expertise is based on application know-how and innovation translating market needs into products and services with new benefits. Technologies in the Nutrition cluster are broad, utilizing DSM’s competences in biotechnology (including fermentation), chemical process technology and particle engineering. DSM is the world’s largest vitamin producer and holds leading positions in the ingredient markets for Human Nutrition & Health, Animal Nutrition & Health as well as Personal Care.
The Performance Materials cluster comprises the business groups DSM Dyneema, DSM Engineering Plastics and DSM Resins & Functional Materials. These business groups specialize in the manufacture of technologically sophisticated, high-quality products that are tailored to meet customers’ performance criteria. DSM is recognized as a front-runner in creating and introducing sustainable innovative solutions. Its performance materials are used in a wide variety of end-use markets including: Automotive/Transportation, Building & Construction, Electrical & Electronics, Marine, Packaging & Graphic Arts, Paint & Coatings and Sports, Leisure & Consumer Goods.
Emerging Business Areas
DSM's Emerging Business Areas provide strong, long-term growth platforms that optimally combine our scientific competences. The company currently has three Emerging Business Areas: DSM Bio-based Products & Services, DSM Biomedical and DSM Advanced Surfaces.
Polymer Intermediates & Composite Resins
On 31 July 2015 DSM and CVC Capital Partners (CVC) announced that with the formation of a new company, ChemicaInvest B.V., the partnership for DSM’s activities in Polymer Intermediates (DSM Fibre Intermediates) and Composite Resins had been finalized.
DSM reports on its investment in ChemicaInvest B.V. as an associated account in accordance with the equity (35%) method rather than as ongoing business. Consequently as of 31 July 2015 the (former) Polymer Intermediates cluster and Composite Resins business are not included in DSM’s core EBITDA or activities.
DSM reports on its investments in Patheon and DSM Sinochem Pharmaceuticals as associated accounts in accordance with the equity (49% & 50% respectively) method rather than as ongoing business. Consequently as of 1 January 2014 the (former) Pharma cluster is not included in DSM’s core EBITDA or activities.